mushroom

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome on CRISPR-Cas antimicrobials

Gene editing

Home » Emerging technologies » Gene editing

mushroom

CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes

-Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused...

mushroom

GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR

Latch Bio Emerges from Stealth with Seed Funding Round Led by Lux Capital

Company launches first-of-its-kind platform for performing no-code CRISPR workflows via any web browser October 01, 2021 07:30 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Latch Bio, a company...

Mammoth Biosciences

Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics

mushroom

Caribou Biosciences Announces Pricing of Upsized Initial Public Offering

mushroom

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

mushroom

CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer

headshots of two women and one man who originally own crispr

Who Owns CRISPR in 2021? It’s Even More Complicated Than You Think

mushroom

EdiGene Raises Approximately USD 62 Million in Series B Plus Financing and Expands Operation Locations to Advance and Scale Up Clinical Translation of Gene Editing Technologies

colored cancer cells

Visualizing the Future: Spatialomics Transforms Study of Gene Expression

Synthego

Synthego Launches Eclipse Platform to Accelerate Research and Development of Next-generation Medicines

mushroom

Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing

mushroom

eGenesis Expands Research Collaboration with Leading Academic Medical Center

mushroom

Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners

mushroom

Graphite Bio Secures $150 Million Series B Financing to Advance Pipeline of Next-Generation Gene Editing Therapies